Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Our study aims to investigate the effect of Irbesartan (the angiotensin II receptor antagonist) on the changes of AGE-RAGE system and MMP family components, and analyzes the potential mechanisms in type 2 diabetes-induced myocardial fibrosis. 31027433 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE For this reason, the purpose of the present study was to determine the effect of 600 mg/day of ALA on the markers of oxidative stress (OxS) and inflammation and RAGE in older adults with T2DM. 31285784 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Tea Polypeptide Ameliorates Diabetic Nephropathy through RAGE and NF-κB Signaling Pathway in Type 2 Diabetes Mice. 30354109 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study. 27448675 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE BAX expression was also significantly higher in the T2DM group, and showed a strong correlation with AGER expression (r = 0.86, p < 0.0001). 27873077 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes. 28811295 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Taken together, our findings highlighted a contributory role of the RAGE gene, especially its two functional variants -429T > C and 82Gly > Ser, in susceptibility to T2DM in primary hypertensive patients, which may aid early detection and risk assessment for high-risk individuals. 29222432 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We aimed to investigate the roles of RAGE, AGEs and the Gly82Ser polymorphism of RAGE in mild cognitive impairment (MCI) among type 2 diabetes patients. 26745632 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE The 2184A/G polymorphism in the AGER gene is not associated with DR in Han Chinese patients with T2DM. 27033231 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Our meta-analysis indicated that the RAGE gene -429CC genotype might be a risk factor for DN in patients with type 2 diabetes. 25707513 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products. 25666934 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Our study indicated that the 2184A/G polymorphism in the RAGE gene was significantly associated with diabetic nephropathy in Chinese Han patients with type 2 diabetes. 26770981 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Our data indicates significant association of RAGE SNPs and haplotypes with vascular complications in North Indian T2DM subjects. 24418399 2014
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Genetic variation of RAGE gene may be associated with the development of vascular complications in type 2 diabetes mellitus (T2DM). 23721855 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease RGD Morpho-mechanical intestinal remodeling in type 2 diabetic GK rats--is it related to advanced glycation end product formation? 23403079 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Our research confirmed an association between the RAGE -374T/A polymorphism and retinopathy in subjects with type 2 diabetes and the -374AA allele was found to be a protective factor for type 2 diabetes. 22354095 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE This meta-analysis suggested that there might be no association of RAGE gene polymorphisms (Gly82Ser, 1704G/T, 429T/C) with T2DM, DR and DN risk. 22475522 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE RAGE gene expression was higher in T2D than in controls (p <0.01). 22100610 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We previously reported the association of the Z-2 allele of the promoter dinucleotide repeat in the Aldose reductase (ALR2) gene, the (CCTTT)₁₅ allele in the promoter of inductible nitric oxide synthase (iNOS) gene, and the (GT)₁₃ promoter polymorphism in the tumor necrosis factor β (TNFB) gene with an increased risk for diabetic retinopathy (DR), and the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene and the (GT)₉ allele of the TNFB gene with low-risk for DR in a hospital-based self-reported type 2 diabetes mellitus (T2DM) patients. 21067489 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE This study confirms significant association of one polymorphism only (rs2070600 in RAGE) with DR in an Indian population which had T2DM. 21067572 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE In conclusion, the -374A allele of the RAGE gene might be a protective factor for vascular complications in T2DM, especially in Caucasians and macrovascular disease. 20410680 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE In individuals with normal glucose metabolism, the -374A allele of the RAGE gene is protectively associated with blood pressure and arterial stiffness, whereas in individuals with impaired glucose metabolism or type 2 diabetes mellitus, it is adversely associated with these variables. 20051912 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE G82S and -429 T/C polymorphisms of RAGE were associated with the circulating levels of esRAGE but not with CAD in Chinese patients with T2DM. 19766904 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease RGD Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats. 19735169 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE G82S polymorphism in the RAGE gene is associated with DR and G-A haplotype containing 1704G and 82S allele might be a genetic marker of DR in Chinese T2DM patients. 19542745 2009